Global Articaine Hydrochloride Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Articaine Hydrochloride Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Ateticaine hydrochloride is the hydrochloride form of the local anesthetic anticaine. Atticaine hydrochloride in combination with specific membrane sodium ion channels reversibly prevents nerve impulse conduction, thereby interfering with electrical stimulation in the nerve, slowing the propagation of nerve impulse and reducing the increase in action potential. This results in loss of sensation at the injection site. Aticacaine hydrochloride is often used in combination with the vasoconstrictor adrenaline to relieve pain during minor operations such as dental surgery.

Market Overview:

The latest research study on the global Articaine Hydrochloride market finds that the global Articaine Hydrochloride market reached a value of USD 1448.4 million in 2022. It’s expected that the market will achieve USD 2316.66 million by 2028, exhibiting a CAGR of 8.14% during the forecast period.

Drivers

Increasing Incidences of Dental Caries and Other Periodontal Diseases
Periodontal disease is an inflammatory disease that occurs in tissues around the teeth, including gingivitis and periodontitis. Gingivitis is mainly plaque that accumulates on the tooth surface and gingival sulcus. Gum inflammation, bleeding and swelling caused by tartar. If the inflammation further develops and causes alveolar bone damage, it develops into periodontitis. A survey by the World Health Organization shows that periodontal disease has become the third largest disease endangering human health after malignant tumors and cardiovascular and cerebrovascular diseases. Especially in developing countries, the prevalence of periodontal disease is very high, and the prevalence of dental caries continues to increase (especially for urban residents). The continued increase in the incidence of periodontal disease has led to an increase in related dental surgery, so it is also promoting the development of the artemisinin hydrochloride market.

Restraints

Alternative Local Anesthesia Available in Developing Countries
Ateticaine hydrochloride, as a local oral anesthetic, has a good anesthetic effect, but the price is high. In some low-income areas, they may find it difficult to afford higher-priced medicines and instead choose alternative medicines with similar effects. Local anesthetics such as Lidocaine, Mepivacaine, Prilocaine, etc. can be used as oral local anesthesia. Lower prices for alternative medicines may attract more consumers, especially in developing countries. This may limit the development of the aticaine hydrochloride market.

Opportunities

With the development of the economy, per capita disposable income has increased, and health concerns have gradually increased. More and more developing countries are investing more in health care. This means that more people can get good oral treatment, which leads to an increase in the number of oral surgeries. With the growth of downstream demand, the market for aticaine hydrochloride has huge market potential in the future.
Innovation also plays an important role in driving market growth. In order to maintain stability in a highly competitive market, suppliers should develop new ideas and technologies and keep pace with advanced technologies. Most manufacturers are continually improving their products to make their products more effective, safer, and less side-effecting with regard to narcotics, thereby gaining a larger market share.

Region Overview:

In global comparison, a significant portion of the revenue was generated in Europe (37.89% in 2022).

Company Overview:

Septodont is one of the major players operating in the Articaine Hydrochloride market, holding a share of 10.79% in 2021.

Septodont

Septodont Ltd. develops and manufactures products for the dental profession. The Company is active in endodontics, impression, infection control, pain control, periodontology and surgical, preventive care, and restorative services.

Sanofi

Sanofi manufactures pharmaceutical products. The Company offers drugs, generic medicines, food supplement, cosmetics, and medical devices such as cancer, cardiology, gynecology, and diabetes. Sanofi serves customers worldwide.

Application Overview:

By application, the Dental Clinics segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Articaine Hydrochloride market covered in Chapter 3:

Laboratorios Normon
3M
Molteni Dental
Dentsply Sirona
Laboratorios Clarben
Produits Dentaires Pierre Rolland
Anhui BBCA Pharmaceutical Co., Ltd
Pierrel Group
Inibsa Dental S.L.U
Septodont
Sanofi

In Chapter 4 and Chapter 14.2, on the basis of types, the Articaine Hydrochloride market from 2018 to 2029 is primarily split into:

Articaine-100
Articaine-200

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Articaine Hydrochloride market from 2018 to 2029 covers:

Dental Clinics
Hospitals
Academics & Research Institutes

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)